ResearchMoz

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

Winter Green Research
Published Date » 2013-02-11
No. Of Pages » 293
   
 WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 293 pages, 67 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need Intraocular Lenses (IOL). All older people develop cataracts. 
   
 Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting. 
   
 Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an...
Table of Content

Intraocular Lens (IOL) Executive Summary
Intraocular Lens Market Driving Forces
Cataract Surgical Technology Is Evolving Rapidly
Patient Populations Have Significant Demand for Cataract Surgery
Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
Cataract Surgery Business
Intraocular Lens Market Challenges
World Population Growth
Intraocular Lens Market Shares
Intraocular Lens Market Forecasts

1. Intraocular Lens Market Description and Market Dynamics
1.1 Cataract Surgical Technology Is Evolving Rapidly
1.1.1 Patient Populations Have Significant Demand for Cataract Surgery
1.1.2 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
1.1.3 Cataract Surgery Business
1.1.4 Intraocular Lens Market Challenges
1.2 World Economy Undergoing A Transformation
1.2.1 Global Economic Conditions:
1.2.2 Global Economy Becomes Steadily More Sluggish
1.2.3 Global Economic Conditions Impact Markets

2. Intraocular Lens Market Shares and Forecasts
2.1 Intraocular Lens Market Driving Forces
2.1.1 Cataract Surgical Technology Is Evolving Rapidly
2.1.2 Patient Populations Have Significant Demand for Cataract Surgery
2.1.3 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
2.1.4 Cataract Surgery Business
2.1.5 Intraocular Lens Market Challenges
2.1.6 World Population Growth
2.2 Intraocular Lens Market Shares
2.2.1 Novartis / Alcon
2.2.2 Novartis / Alcon Competitive Situation
2.2.3 Novartis / Alcon Competition
2.2.4 Novartis Alcon Multifocal Lenses
2.2.5 Novartis / Alcon
2.2.6 Novartis / Alcon
2.2.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.2.8 LenSx Acquired by Alcon
2.2.9 Abbott Medical Optics
2.2.10  Abbott Medical Optics / Visiogen’s Synchrony
2.2.11  Abbott Tecnis
2.2.12  Abbott TECNIS® IOLs
2.2.13  Bausch & Lomb Presbyopic IOLs
2.2.14  Bausch + Lomb
2.2.15  Bausch + Lomb Eye Surgical Technologies In The Pipeline
2.2.16  Bausch + Lomb: Accommodating IOLs
2.2.17  Bausch + Lomb:  Crystalens IOL
2.2.18  OptiMedica
2.2.19  Staar Acrylic IOL
2.2.20  Staar
2.2.21  Staar Silicone IOLs
2.2.22  Staar® Surgical Company nanoFLEX IOL
2.2.23  Staar Visian
2.2.24  LensAR
2.2.25  PhysIOL's FineVision
2.2.26  IOL Research and New Lenses
2.2.27  ReSTOR Multifocal Toric AcrySof IQ
2.2.28  Abbott Tecnis One-Piece Toric
2.2.29  Lenstec Tetraflex
2.2.30  Calhoun Vision Light-Adjustable Lens
2.2.31  Abbott Visiogen Synchrony
2.2.32  Rayner M-flex T
2.2.33  NuLens DynaCurv
2.2.34  Carl Zeiss AcriLisa Diffractive Multifocal Toric
2.2.35  Bausch + Lomb’s Crystalens Toric
2.2.36  Hoya’s Adoptics
2.3 Intraocular Lens Market Forecasts
2.3.1 Intraocular Lens Market Segment Forecasts
2.3.2 Number of Cataract Surgeries Per Year
2.3.3 Novartis Positioning with Sales and Marketing Resource
2.3.4 Bausch + Lomb Small Incisions
2.3.5 Femtosecond Technology Is Game Changer
2.3.6 Intraocular Lens Unit Analysis
2.3.7 Aspheric Foldable IOL Lens
2.3.8 Intraocular Lens Presbyopia Market Forecasts
2.3.9 Market Trend:  Monofocal IOL Channel Will Be Slowly But Continuously Eroded By The Multifocal IOL
2.3.10  Presbyopia-Correcting Intraocular Lens (IOL)
2.3.11  Premium Channel Surgeons
2.3.12  Market Trend:  Accommodating IOL Channel to Grow
2.3.13  Market Trends:  Diffractive Lenses
2.3.14  Market Trend:  Multifocal IOLs
2.3.15  Market Trend:  Surgical Workstation
2.3.16  Premium IOL Forecasts
2.3.17  Technologies Driving Intraocular Lens IOL Market Growth
2.3.18  Diffractive IOLs
2.3.19  Large Middleclass Population Base Driving Intraocular Lens IOL Market Growth
2.3.20  Nonfoldable Polymethylmethacrylate/Plexiglas Based Lenses To Silicone And Acrylic Based Foldable Lenses
2.3.21  Global Vision Care and Ocular Market
2.4 Intraocular Lens Prices
2.4.1 Premium Lens Technology Reimbursement Trends
2.4.2 CMS Medicare Intorocular Reimbursement Guidelines
2.5 Intraocular Lens Regional Market
2.5.1 Eye Surgical Techniques by Country
2.5.2 United States
2.5.3 Canada
2.5.4 Brazil Cataract Surgical Procedure
2.5.5 Brazilian  Cataract surgeries
2.5.6 China
2.5.7 Toric Lens Implantations On The Rise In Europe
2.5.8 Advanced Technology Intraocular Lens Growth Markets
2.5.9 Cataract Surgery in the UK
2.5.10  Asia-Pacific Cataract Surgery
2.5.11  Cataract Surgery in India
2.5.12  Cataract Surgery Assembly Line Systemm Followed At Aravind Eye Hospitals
2.5.13  Aurolab’s Low-Cost, High-Volume Business Model
2.5.14  Highly Efficient Operations Coupled With Pricing Structure Allow 50% Profit Margin
2.5.15  World Health Organization (WHO),

3. Intraocular Lens (IOL) Product Description
3.1 IOL lenses
3.2 Novartis / Alcon
2.1.1 Novartis / Alcon
2.1.2 Novartis / Alcon Competitive Situation
2.1.3 Novartis / Alcon Competition
2.1.4 Novartis Alcon Multifocal Lenses
2.1.5 Novartis / Alcon
2.1.6 Novartis / Alcon
2.1.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.1.8 LenSx Acquired by Alcon
3.3 Abbott Medical Optics / Visiogen’s Synchrony
3.3.1 Abbott Medical Optics Synchrony
3.3.2 Abbott Medical Optics’
3.3.3 Abbott Medical Optics / Visiogen’s Synchrony Lens
3.4 Bausch & Lomb / Crystalens
3.4.1 Bausch & Lomb Crystalens AO Lens
3.4.2 Bausch + Lomb: Accommodating IOLs
3.4.3 Bausch + Lomb:  Crystalens IOL
3.4.4 Bausch & Lomb Crystalens HD
3.5 Calhoun Vision’s Light Adjustable Lens
3.6 NuLens
3.7 PixelOptics
3.8 Imperial Medical Technologies’
3.9 Presbia’s Flexivue
3.10 Lenstec’s Tetraflex Lens
3.11 Staar
3.11.1  STAAR® Surgical Company nanoFLEX IOL
3.11.2  Staar Elastimide® Silicone Aspheric IOL
3.11.3  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.4  Staar Afinity™ Collamer® Aspheric IOL
3.11.5  STAAR Toric™ IOL
3.11.6  Staar Afinity™ and nanoFLEX™ Collamer Aspheric IOLs
3.11.7  Staar Collamer Advantage
3.11.8  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.9  STAAR Surgical Elastimide Silicone Aspheric IOL Model AQ2015A
3.11.10  STAAR Elastimide Lens Model AQ2003V
3.11.11  STAAR Elastimide Lens Model AQ2010V
3.11.12  STAAR Elastimide Lens Model AQ5010V - Low Diopter
3.11.13  STAAR Elastimide Lens Model AQ2017V (Discontinued)
3.11.14  STAAR Elastimide Lens Model AQ1016V (Discontinued)
3.11.15  STAAR Elastic Lens Model AA4204VF
3.11.16  STAAR Elastic Lens Model AA4204VL
3.11.17  STAAR Elastic Lens Model AA4207VF (Discontinued)
3.11.18  STAAR Toric Silicone Single Piece IOL
3.11.19  STAAR Elastic Toric Lens Model AA4203TL
3.11.20  Canon-STAAR Preloaded IOL Model KS-3Ai
3.12 Lxenstec’s Tetraflex
3.12.1  Lxenstec’s Tetraflex Manufactured To A Tenth Of A Diopter Toleranc3-e
3.12.2  Lxenstec Elenza Lens
3.13 Hoya
3.14 Tecnis MF
3.14.1  PowerVision (Belmont, Calif.), Oculentis (Berlin), and PhysIOL (Liège, Belgium
3.14.2  PowerVision's FluidVision
3.14.3  FluidVision
3.15 MPlus by Oculentis
3.16 PhysIOL's FineVision
3.17 WaveTec Vision
3.18 Pediatric Cataract / Intraocular Lenses (IOL)
3.18.1  4 D change in power is needed between ages 10 and 20
3.18.2  Correcting Astigmatism in Pediatric Patients

4. Intraocular Lens (IOL) Technology
4.1 The Human Eye
4.2 Cataracts
4.2.1 Staar Collamer
4.2.2 Cataract Symptoms
4.2.3 Benefits Of Cataract Eye Surgery
4.2.4 How Cataract Eye Surgery Is Performed
4.3 Intraocular Tens Technology
4.3.1 Technologies Driving Intraocular Lens IOL Market Growth
4.4 Aspheric Contact Lenses
4.5 Refractive Disorders
4.6 Studies On The Restor Toric Lens
4.6.1 MNRead Functional Reading Test
4.7 Surgeons Need To Concentrate On Proper Patient Selection
4.8 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses
4.8.1 Obesity Cause of Diabetes and Neuropathy of the Eye

5. Intraocular Lens (IOL) Company Description
5.1 Abbott Laboratories
5.1.1 Abbott Acquired Visiogen with Synchrony Product
5.1.2 Abbott Labs Cataract Company Acquisitions
5.1.3 Abbott Completes Separation of Research-Based Pharmaceuticals Business
5.1.4 Abbott (NYSE: ABT) Separation Of Its Research- Based Pharmaceuticals Business
5.1.5 Abbott Separating Into Two Independent Companies
5.1.6 Abbott Laboratories and Subsidiaries Revenue
5.1.7 Abbott Sales Mix
5.1.8 Abbott Nutritional Market Presence
5.1.9 Abbott Diagnostics Market Presence
5.1.10  Abbott Medical Devices Market Presence
5.1.11  Abbott Strength Through Ability to Innovate
5.1.12  Abbott Revenue
5.1.13  Abbott Medical Optics
5.1.14  Abbott Medical Optics Corneal Products
5.1.15  Abbott Medical Optics Refractive Product Line
5.1.16  Abbott Medical Optics Cataract Products
5.1.17  Abbott Medical Optics Technological Innovation
5.2 Akkolens
5.2.1 AkkoLens Features
5.2.2 AkkoLens Clinical Partners
5.3 Allergan
5.3.1 Allergan Flagship Franchises In Eye Care, Neurosciences,Medical Dermatology And Urologics
5.3.2 Allergan Acquisition of Inamed Corporation
5.3.3 Allergan Specialty Product Lines Focused On High-Growth Markets
5.3.4 Allergan Global in reach. Specialized in focus
5.3.5 Allergan Leading Products
5.3.6 Allergan/  SkinMedica, Inc. Acquisition
5.3.7 Allergan Obesity Intervention
5.4 Aravind
5.4.1 Future of Aravind
5.5 Bausch And Lomb
5.5.1 Bausch + Lomb Vision Care
5.5.2 Bausch + Lomb Pharmaceuticals
5.5.3 Bausch + Lomb Cataract and Vitreoretinal Surgery
5.5.4 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.5 Bausch + Lomb Technolas® Perfect Vision
5.5.6 Bausch + Lomb Technolas® Perfect Vision Transforming Refractive Surgery
5.5.7 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.8 Technolas Perfect Vision
5.6 Biovision
5.7 Elenza
5.8 Kowa Company, Ltd.Environmental & Energy Saving Products
5.9 Hoya
5.9.1 Hoya, Seiko And Epson; Agreements Executed In The Field Of Optical Products Business
5.9.2 Hoya Second Quarter Revenue
5.10 Lenstec
5.11 Novartis Group / Alcon
5.11.1  Novartis Alcon Division
5.11.2  Novartis Revenue
5.11.3  Alcon Cataract Surgery
5.11.4  Alcon Surgical Glaucoma
5.11.5  Alcon Vitreoretinal
5.11.6  Alcon Refractive Surgery
5.11.7  Alcon Acquires Leading Ocular Surgical Guidance Technology
5.11.8  Alcon
5.11.9  Alcon Acquired The Ophthalmic Division of SensoMotoric Instruments (SMI)
5.11.10  Alcon Division Surgical Products
5.11.11  Alcon Ophthalmic Pharmaceuticals
5.11.12  Alcon Products
5.11.13  Alcon Cataract Reimbursement
5.11.14  Alcon Regulation
5.11.15 LenSx Acquired by Alcon
5.12 OptiMedica
5.12.1  Catalys next generation laser cataract surgery platform
5.13 Physiol
5.13.1  Physiol Multifocal IOL FineVision (Micro F) 2
5.14 Rayner
5.14.1  Surgery on 109 Year old Woman Using Rayner IOL
5.15 Staar Surgical
5.15.1  STAAR Surgical Devices Used In Corrective Surgery
5.15.2  STAAR Surgical Minimally Invasive Intraocular Lenses (IOLs).
5.16 WaveTec Vision®
5.16.1  WaveTec Vision Secures $16.5m To Market Cataract Surgery System
5.17 Zeiss –
5.17.1  Zeiss Vision
5.17.2  Zeiss Revenue
5.18 Selected Companies in the Market

List of Tables


Table ES-1 Intraocular Lens Market Driving Forces
Figure ES-2 Advanced Technology Intraocular Lens Growth Drivers
Table ES-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift.
Table ES-3 Intraocular Lens Market Challenges
Table ES-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Figure ES-5 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 1-1 Cataract Surgery Diverse Market Growth Drivers
Table 1-2 Intraocular Lens Market Challenges
Table 2-1 Intraocular Lens Market Driving Forces
Figure 2-2 Advanced Technology Intraocular Lens Growth Drivers
Table 2-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift
Table 2-3 Intraocular Lens Market Challenges
Table 2-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Table 2-5 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
Table 2-6 Novartis Cataract Surgical Techniques
Figure 2-7 Novartis / Alcon Overview of Surgical Franchise
Figure 2-8 Alcon Key Intraocular Lenses (IOLs) Products
Table 2-9 Novartis / Alcon IOL Market Strategic Positioning
Figure 2-10 Bausch + Lomb Crystalens® is an FDA-approved intraocular lens
Table 2-11 ReSTOR’s Acrylic Material Helps Keep It From Rotating Postop
Figure 2-12 Abbott Tecnis Toric IOL
Figure 2-13 Lenstec Tetraflex
Figure 2-14 Abbott Visiogen Synchrony
Figure 2-15 NuLens DynaCurv
Figure 2-16 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 2-17 Intraocular Lens Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-18 Low End Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Figure 2-19 Premium Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Table 2-20 Intraocular Lens (IOL) Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-21 Intraocular Lens (IOL), Market Forecasts, Units, Worldwide, 2013-2019
Figure 2-22 Novartis Franchise Dedicated Resources
Figure 2-23 Cataract Surgery Pathophysiology, Prevalence, and Surgical Techniques
Table 2-24 Intraocular Lens Description
Table 2-25 Intraocular Lens Advanced Technology
Figure 2-26 Novartis Commentary on Cataracts as Leading Cause of Reversible Blindness
Figure 2-27 Intraocular Lens (IOL) Regional Market Segments, Dollars,  2012
Table 2-28 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide, Dollars, Worldwide, 2013-2019
Table 2-29 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide Percent, Worldwide, 2013-2019
Figure 2-30 Eye Surgical Techniques by Country 
Figure 3-1 Novartis / Alcon Key Intraocular Lenses (IOLs) Products
Table 3-2 Novartis Cataract Surgical Techniques
Figure 3-3 Novartis / Alcon Overview of Surgical Franchise
Table 3-4 Novartis / Alcon IOL Market Strategic Positioning
Table 3-5 Abbott Medical Optics Cataract Products
Table 3-6 Abbott Medical Visiogen’s Synchrony lens Advantages
Table 3-7 Abbott Medical Visiogen’s Synchrony Lens Disadvantages
Figure 3-8 Bausch + Lomb Crystalens® FDA-Approved Intraocular Lens
Figure 3-9 Bausch + Lomb:  Crystalens IOL Features
Figure 3-10 STAAR® Surgical Company nanoFLEX IOL
Figure 3-11 Staar Implantable Collamer® Lens for Quality of Vision
Table 3-12 Staar IOL Products
Figure 3-12 Staar Toric Visual Acuity
Figure 3-13 Hoya Pre-Loaded IOL Delivery System “iSert™
Figure 4-1 Human Eye
Figure 4-2 Staar nanoFLEX
Figure 4-3 Staar nanoFLEX  Collamer has a built in Anti-Reflective Interface
Figure 4-4 Staar Hydrophilic Collamer Ultra-High Water Content Layer On Its Surface Minimizing The Difference In Refractive Index
Figure 4-5Staar nanoFLEX™ Collamer Percentage of Light Reflectance
Figure 4-6 Staar nanoFLEX™ Collamer Single Piece IOL
Figure 4-7 Staar nanoFLEX™ Collamer Incision Size
Figure 4-8 Staar nanoFLEX™ Collamer Protective Layer
Figure 4-9 Staar Afinity 3-Piece Collamer Aspheric IOL Model CQ2015A
Function 4-10 Modulation Transfer Function (MTF) Analysis
Table 4-11 Cataract Symptoms
Table 5-1 AkkoLens Technological Features
Table 5-2 AkkoLens Medical Features
Figure 5-3 Hoya IOL plant in Singapore
Figure 5-4 Novartis / Alcon Positioning in Healthcare
Figure 5-5 Novartis Resource By Segment
Figure 5-6 Novartis Surgical Franchise

List of Figures

NA

Upcoming Reports:

Pneumonia Drugs & Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to...
Poland: fruit beverages market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fruit beverages market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fruit beverages market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Fatty Alcohols Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Fatty alcohols are oleochemicals which are colorless waxy solids primarily derived from natural fats and oils. In addition, fatty alcohols can be manufactured synthetically from petrochemicals such as olefins and paraffin. Fatty alcohols are mainly used in manufacture of detergents and surfactants. Moreover, they are used in various other applications such personal care products, textiles and leather, agriculture, polymer processing and printing. Fatty alcohols perform various functions such as solubilizing, floatation, lubricant, emulsifier and superfatting. Escalating demand...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Motor Co.s Shares Suffer Downfall as Lower Profit Outlook for 2014-2015 Surface
Oct 1, 2014  
Suffering from higher recall costs in its North American market and great losses in South America and Russia have made Ford motor Co. to cut-down its forecast regarding pretax profit this year to $6 billion from $7 billion to $8 billion as earlier mentioned.  Company’s CFO Bob Shanks said that company’s pretax profit in 2015 is expected to rise between $8.5 and $9.5...
Evereadys Kenya Plant to be Shut Down
Sep 30, 2014  
The largest dry-cell battery manufacturer in the region of East Africa, Eveready East Africa Ltd. intends on shutting down its one and only factory in Kenya on the 1st of October 2014. A real estate business will be started in its place. According to the Managing Director of Eveready East Africa Ltd. the plan of shutting down the plant was initiated by the board members of this company...
Sale of Apples iPhones Remains Unaffected - Supported By Consumer Feedback
Sep 29, 2014  
iPhones have been reintroduced in the global market by Apple Inc. in about 22 countries. Consumer reports and feedback basically show that due to the presence of a problem-free backing and update, these handsets are sturdy and do not bend easily. It has been observed via stress tests conducted on iPhone 6 and 6 Plus, that it requires high force and pressure to cause damage to these...
New Malware Targets Pharma Servers
Sep 29, 2014  
The electronics and communication agency Beldon has reportedly spotted a new cyber threat to the pharmaceutical industry. Called Dragonfly, the malware specifically targets intellectual property of servers in the pharmaceutical industry with the purpose of stealing information. An initial report released by ipprolifesciences.com stated the malware was targeting the energy sector....
Child’s Success Depends on Father’s Education Level: Study
Sep 24, 2014  
A father’s level of education is the strongest attribute that can determine a child’s success in academics, according to a research conducted in Britain. It also says that there is a self-reinforcing cycle of lack of achievement and poverty that is handed down from parent to child. The report was released by the Office for National Statistics and states that children are...